about
Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogeneMetastasis-associated PRL-3 induces EGFR activation and addiction in cancer cellsRegulatory mechanisms of phosphatase of regenerating liver (PRL)-3Comprehensive assembly of novel transcripts from unmapped human RNA-Seq data and their association with cancerTumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent mannerPRL-3 promotes telomere deprotection and chromosomal instability.VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2CA role of autophagy in PTP4A3-driven cancer progression.Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD-negative acute myeloid leukemia.PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasionPoor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progressionPRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver.The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer.Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice.PRL-3 activates mTORC1 in Cancer Progression.The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaInhibition of PRL-2·CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth.PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer.Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.PRL-3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma.PRL3-zumab, a first-in-class humanized antibody for cancer therapy.Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transductionIdentification of proteins suppressing the functions of oncogenic phosphatase of regenerating liver 1 and 3.PRL-3 disrupts epithelial architecture by altering the post-mitotic midbody positionPhosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.Phosphatase of regenerating liver 2 (PRL2) deficiency impairs Kit signaling and spermatogenesis.Molecular mechanisms of the PRL phosphatases.Tapping the treasure of intracellular oncotargets with immunotherapy.Molecular targets and pathways involved in liver metastasis of colorectal cancer.Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.Thioredoxin-related protein 32 (TRP32) specifically reduces oxidized phosphatase of regenerating liver (PRL).Downregulation of phosphatase of regenerating liver-3 is involved in the inhibition of proliferation and apoptosis induced by emodin in the SGC-7901 human gastric carcinoma cell line.Targeting intracellular oncoproteins with antibody therapy or vaccination.Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.
P2860
Q27326713-920B606C-24E2-4D3B-82E0-5CC611456553Q27852452-BC982B37-C85C-4A1E-9696-4BB57D2481D0Q28066318-6FC98FEE-5EE9-4B6D-A8AE-06E9E6CE3707Q30985845-BE316CE0-865B-4BAD-88BC-941BD032331AQ33624421-8C9C8CAF-57B4-44CE-B383-D0EB5A3DA3ADQ33878962-F9625B19-8C62-4F33-8D22-7F41BA1A223DQ34071838-433AC6E9-5FAE-4ADD-BFE4-8E29F61D994EQ34344700-D68B7BB1-561A-4DB5-9E25-35A112DA6298Q34455621-309F5A8F-7DA3-44D6-A90F-B2723D93DBADQ34507306-891CCA5E-1DDC-4BF6-BA90-A576D0BF81D1Q34590459-E4458810-FF2E-4677-9B33-DD5A36CD2428Q34731436-96BB73A7-3093-47A4-95B5-C629B8C4D290Q35034895-6710B44E-081E-431B-A66C-A0F8C45E3B38Q35145340-B7C08E3D-9BDD-4309-A06C-80E813C04AF5Q35163691-6FDC003A-7F6D-4A77-8269-0898432ED65CQ35232366-E9990941-9D2A-4E3D-A739-7DE0B1278FA7Q35867697-F9633C99-F6B7-486F-9319-7C49943CF0DAQ35889827-DF8E12CC-61A1-4D30-B6D4-809068B3CD0BQ36310169-914663E8-986E-4E60-8E30-13A328D76B1EQ36510458-2D732B84-9A72-46E7-A48F-F51B9A58AE1BQ36898255-9787F3C2-6986-4C72-9301-40A9FB09A71BQ37204478-370EEF7D-6E20-4E52-8C46-7A677387C971Q37236903-001893BD-D348-4333-BFAB-415017E053D5Q37275484-DA282CBF-ADED-423D-9C4D-EAA5209C804CQ37277211-ACC0F130-35EC-48C7-938E-2059F30D1387Q37389005-2A9ECD1F-BA35-40B5-A2EC-CD629BE5102CQ37406431-DD2CAD46-403B-4FE7-93A7-3507A4844796Q37425927-4A631C9A-E5E0-49E1-B51D-EF6E90230025Q37426883-BF1AFF83-72CA-4887-B27F-E1FE6DA28E7BQ37563586-3E628AF8-5AD7-4B19-8323-7CE4F8D6F99BQ37993157-45207448-C3F5-43B9-84FC-BB30BA4D946AQ38159081-98E052AB-2DF4-4BB7-9AC0-0312A22F6397Q38535666-B9CE8968-D888-4BEF-BC14-26160646392BQ38644355-5B6C40AB-F3CA-42E5-8571-5737CCBCEF0EQ38791488-58F23AB4-2294-41D7-BD06-6821502025CAQ38821051-538DB419-BA30-49FA-8E04-4436AA902C1BQ39202231-644E6107-A9FF-46E8-BAD4-7DB6044B349CQ39280610-EBCABAD1-AC37-4351-B288-B98447165E0BQ39477768-62ECD247-EC31-4EA9-8528-9205EB9C775FQ43522873-466A2157-CA4B-42F9-AF93-7A6A44C7C886
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PRL-3 phosphatase and cancer metastasis.
@en
PRL-3 phosphatase and cancer metastasis.
@nl
type
label
PRL-3 phosphatase and cancer metastasis.
@en
PRL-3 phosphatase and cancer metastasis.
@nl
prefLabel
PRL-3 phosphatase and cancer metastasis.
@en
PRL-3 phosphatase and cancer metastasis.
@nl
P2860
P356
P1476
PRL-3 phosphatase and cancer metastasis.
@en
P2093
Abdul Qader O Al-Aidaroos
P2860
P304
P356
10.1002/JCB.22913
P577
2010-12-01T00:00:00Z